Association between retinol binding protein 4 with atherosclerotic markers in obese children

Nalini Santanam1, Yoram Elitsur, Ronald Stanek

  • 1Department of Pharmacology, Physiology and Toxicology, Joan C Edwards School of Medicine, Marshall University, Huntington, WV, USA - santanam@marshall.edu.

Minerva Endocrinologica
|October 31, 2014
PubMed

Insights

Obese children show higher levels of Retinol-binding protein-4 (RBP4) and oxidized-low-density lipoprotein (Ox-LDL), which are linked to increased cardiovascular risk. These markers correlate with higher BMI and waist circumference in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Risk Factors
  • Adipokine Research

Background:

  • Childhood obesity is a growing concern, significantly increasing adult cardiovascular disease risk.
  • Retinol-binding protein-4 (RBP4), a pro-inflammatory adipokine, is implicated in obesity, insulin resistance, and adult atherogenesis.
  • Understanding RBP4's role in pediatric obesity is crucial for early cardiovascular risk assessment.

Purpose of the Study:

  • To investigate the relationship between RBP4 and key atherogenic markers in obese children.
  • To explore correlations between RBP4, oxidized-low-density lipoprotein (Ox-LDL), and anthropometric measures in pediatric obesity.

Main Methods:

  • A cross-sectional study involving obese and non-obese children aged 8-18 years.
  • Measurement of clinical markers including lipid profile, HbA1c, insulin resistance markers, plasma RBP4, sVCAM-1, and Ox-LDL.
  • Analysis of correlations between RBP4, Ox-LDL, and anthropometric indices like Body Mass Index (BMI) and waist circumference.

Main Results:

  • Obese children exhibited significantly higher plasma levels of RBP4 (P=0.016) and Ox-LDL (P<0.001) compared to non-obese peers.
  • Both RBP4 and Ox-LDL showed positive correlations with Body Mass Index (BMI) (P<0.001), BMI-SDS (P<0.001), and waist circumference (P=0.03).

Conclusions:

  • Elevated RBP4 and Ox-LDL are associated with obesity in children.
  • These findings suggest RBP4 and Ox-LDL may serve as early indicators of cardiovascular risk in pediatric obesity.
  • No significant correlations were observed between inflammatory markers and Homeostatic Model Assessment-2, HDL, triglycerides, or HbA1c in the studied obese children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
748
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
430
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
835